Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.44 |
| ▸ | HTT | P42858 | 3/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.44 |
| ▸ | NPC1 | O15118 | 2/20 | 0.44 |
| ▸ | RAB9A | P51151 | 2/20 | 0.44 |
| ▸ | GLA | P06280 | 2/20 | 0.44 |
| ▸ | TSHR | P16473 | 2/20 | 0.44 |
| ▸ | POLB | P06746 | 1/20 | 0.44 |
| ▸ | ATM | Q13315 | 1/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.42 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.42 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.42 |
| ▸ | CRHBP | P24387 | 1/20 | 0.41 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.41 |
| ▸ | DAO | P14920 | 1/20 | 0.41 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.41 |
| ▸ | CES2 | O00748 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5706292 | 0.89 | NPSR1 (0.56) | NPSR1ALDH1A1HTTKMT2ANPC1 | |
| SCHEMBL1409829 | 0.85 | NPSR1 (0.46) | NPSR1ALDH1A1HTTKMT2ANPC1 | |
| SCHEMBL8583028 | 0.85 | NPSR1 (0.46) | NPSR1ALDH1A1HTTKMT2ANPC1 | |
| SCHEMBL7080162 | 0.85 | NPSR1 (0.46) | NPSR1ALDH1A1HTTKMT2ANPC1 | |
| SCHEMBL4419504 | 0.85 | NPSR1 (0.46) | NPSR1ALDH1A1HTTKMT2ANPC1 | |
| SCHEMBL4690660 | 0.85 | NPSR1 (0.46) | NPSR1ALDH1A1HTTKMT2ANPC1 | |
| SCHEMBL4690665 | 0.85 | CRHBP (0.53) | NPSR1ALDH1A1HTTKMT2ANPC1 | |
| Hydrochloric Acid SCHEMBL11686695 | 0.83 | CRHBP (0.51) | NPSR1ALDH1A1HTTKMT2ANPC1 | |
| Hydrochloric Acid SCHEMBL11791075 | 0.83 | NPSR1 (0.44) | NPSR1ALDH1A1HTTKMT2ANPC1 | |
| SCHEMBL27685166 | 0.83 | L3MBTL1 (0.50) | NPSR1ALDH1A1KMT2ARAB9ATSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 136 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114514251-A | Polymer dispersions and fabric conditioning compositions comprising the same | 罗地亚经营管理公司 | 2022-05-17 | — | — | CN | claimed |
| CN-109503419-A | A kind of alternately bilayer azobenzene/graphene composite energy-storage material and preparation method | 天津大学 | 2019-03-22 | — | — | CN | claimed |
| CN-109503420-A | A kind of dual graft azobenzene/graphene composite energy-storage material and preparation method | 天津大学 | 2019-03-22 | — | — | CN | claimed |
| US-8951499-B2 | Trifunctional reagent for conjugation to a biomolecule | UNIVERSITY OF WASHINGTON (US) | 2015-02-10 | — | — | US | claimed |
| US-20140179877-A1 | MACROMOLECULE CONJUGATE | BIOTECH IGG AB (SE) | 2014-06-26 | — | — | US | claimed |
| US-20110014151-A1 | MACROMOLECULE CONJUGATE | BIOTECH IGG AB (SE) | 2011-01-20 | — | — | US | claimed |
| EP-1095274-B1 | TRIFUNCTIONAL REAGENT FOR CONJUGATION TO A BIOMOLECULE | DEPT OF RADIATION ONCOLOGY UNI (US) | 2010-09-29 | — | — | EP | claimed |
| US-20100135976-A1 | ADSORPTION DEVICE | NILSSON RUNE | 2010-06-03 | — | — | US | claimed |
| EP-2035061-A1 | AN ADSORPTION DEVICE | Biotech - IgG AB (SE) | 2009-03-18 | — | — | EP | claimed |
| US-20080267865-A1 | Targeting of Erb Antigens | BIOTECH IGG AB | 2008-10-30 | — | — | US | claimed |
| US-20050271673-A1 | Trifunctional reagent for conjugation to a biomolecule | GLYCOREX TRANSPLANTATION AB (SE) | 2005-12-08 | — | — | US | claimed |
| EP-1569690-A1 | ANTILYMPHOMA TARGETING AGENTS WITH EFFECTOR AND AFFINITY FUNCTIONS LINKED BY A TRIFUNCTIONAL REAGENT | Mitra Medical Technology AB (SE) | 2005-09-07 | — | — | EP | claimed |
| WO-2005051424-A1 | TARGETING OF ERB ANTIGENS | MITRA MEDICAL AB (SE) | 2005-06-09 | — | — | WO | claimed |
| WO-2004054615-A1 | ANTILYMPHOMA TARGETING AGENTS WITH EFFECTOR AND AFFINITY FUNCTIONS LINKED BY A TRIFUNCTIONAL REAGENT | MITRA MEDICAL TECHNOLOGY AB (SE) | 2004-07-01 | — | — | WO | claimed |
| US-20010023288-A1 | Trifunctional reagent for conjugation to a biomolecule | GLYCOREX TRANSPLANTATION AB (SE) | 2001-09-20 | — | — | US | claimed |
| US-5958373-A | Polychelants as contrast enhancing agents | NYCOMED SALUTAR INC. (US) | 1999-09-28 | — | — | US | claimed |
| EP-0717737-B1 | CHELANTS AS CONTRAST ENHANCING AGENTS | NYCOMED SALUTAR INC (US) | 1999-04-07 | — | — | EP | claimed |
| EP-0717737-A1 | CHELANTS AS CONTRAST ENHANCING AGENTS | NYCOMED SALUTAR, INC. (US) | 1996-06-26 | — | — | EP | claimed |
| WO-1995007270-A1 | CHELANTS AS CONTRAST ENHANCING AGENTS | NYCOMED SALUTAR, INC. (US) | 1995-03-16 | — | — | WO | claimed |
| US-5189154-A | Ink jet printing dyes | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1993-02-23 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20010023288-A1 | Trifunctional reagent for conjugation to a biomolecule | CD40, UACA, CD47 | NPSR1 2303/4885ALDH1A1 435/4885HTT 3409/4885 |
| US-20050271673-A1 | Trifunctional reagent for conjugation to a biomolecule | UACA, TNFRSF1A, TNFSF11 | NPSR1 2454/4885ALDH1A1 295/4885HTT 1350/4885 |
| US-20080267865-A1 | Targeting of Erb Antigens | ESR1, ESR2, ESRRG | NPSR1 2012/4885ALDH1A1 2257/4885HTT 3330/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.